Prenetics Global Ltd SEC filings PRE
Prenetics Global Ltd has 271 filings in SEC EDGAR's recent list, going back to Sep 16, 2021. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 11, 2025 | — |
| CORRESP | Letter to the SEC | Sep 9, 2025 | — |
| CORRESP | Letter to the SEC | Sep 8, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2025 | — |
| CORRESP | Letter to the SEC | Aug 22, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2025 | — |
| EFFECT | Filing | Feb 16, 2024 | — |
| CORRESP | Letter to the SEC | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 2, 2024 | — |
| CORRESP | Letter to the SEC | Feb 1, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 26, 2024 | — |
| EFFECT | Filing | Nov 2, 2023 | — |
| RW | Filing | Oct 6, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2023 | — |
| CORRESP | Letter to the SEC | Sep 5, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2023 | — |
| CORRESP | Letter to the SEC | Aug 18, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2023 | — |
| CORRESP | Letter to the SEC | Aug 7, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 4, 2023 | — |
| CORRESP | Letter to the SEC | Jul 28, 2023 | — |
| EFFECT | Filing | Jul 20, 2023 | — |
| CORRESP | Letter to the SEC | Jul 19, 2023 | — |
| CORRESP | Letter to the SEC | Jul 14, 2023 | — |
| CORRESP | Letter to the SEC | Jul 12, 2023 | — |
| CORRESP | Letter to the SEC | Jul 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 14, 2023 | — |
| CORRESP | Letter to the SEC | May 31, 2023 | — |
| UPLOAD | Letter from the SEC | May 11, 2023 | — |
| EFFECT | Filing | Dec 14, 2022 | — |
| EFFECT | Filing | Jun 30, 2022 | — |
| CORRESP | Letter to the SEC | Jun 28, 2022 | — |
| CORRESP | Letter to the SEC | Jun 21, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2022 | — |
| CORRESP | Letter to the SEC | Jun 10, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2022 | — |
| RW | Filing | May 27, 2022 | — |
| 20FR12B | Filing | May 24, 2022 | — |
| CERT | Filing | May 18, 2022 | — |
| 8-A12B | Form 8-a12b | May 17, 2022 | — |
| 425 | Filing | May 12, 2022 | — |
| 425 | Filing | May 4, 2022 | — |
| SEC STAFF LETTER | Filing | Apr 12, 2022 | — |
| 425 | Filing | Apr 12, 2022 | — |
| 425 | Filing | Apr 12, 2022 | — |
| EFFECT | Filing | Apr 8, 2022 | — |
| CORRESP | Letter to the SEC | Apr 6, 2022 | — |
| 425 | Filing | Mar 31, 2022 | — |
| CORRESP | Letter to the SEC | Mar 30, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2022 | — |
| CORRESP | Letter to the SEC | Mar 4, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2022 | — |
| CORRESP | Letter to the SEC | Feb 18, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2022 | — |
| CORRESP | Letter to the SEC | Jan 19, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2022 | — |
| CORRESP | Letter to the SEC | Dec 30, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2021 | — |
| CORRESP | Letter to the SEC | Dec 16, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 10, 2021 | — |
| 425 | Filing | Dec 8, 2021 | — |
| 425 | Filing | Dec 6, 2021 | — |
| CORRESP | Letter to the SEC | Nov 30, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 23, 2021 | — |
| SEC STAFF LETTER | Filing | Nov 19, 2021 | — |
| CORRESP | Letter to the SEC | Nov 9, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 28, 2021 | — |
| 425 | Filing | Oct 27, 2021 | — |
| DRSLTR | Filing | Sep 30, 2021 | — |
| DRS | Filing | Sep 30, 2021 | — |
| 425 | Filing | Sep 20, 2021 | — |
| 425 | Filing | Sep 20, 2021 | — |
| 425 | Filing | Sep 17, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
| 425 | Filing | Sep 16, 2021 | — |
Showing 92 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRE (Nasdaq), PRENW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Quarry Bay, Hong Kong
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1876431
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.